Total
0
Shares
LBT Innovations (ASX:LBT) - Chair Elect Joanne Moss
Chair Elect Joanne Moss
Source: Ellume
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • LBT Innovations (LBT) appoints Joanne Moss as the company’s new Chair-Elect as it looks to rejuvenate its board
  • Ms Moss will begin working for LBT as a Non-Executive Director before moving into the Chair role later this year
  • The company says the new leader brings experience in US commercialisation, deal strategy, scale-up and capital raising to the role
  • While current Chair Kate Costello welcomed the appointment and says she will retire after helping support the transition
  • LBT shares are up 5.26 per cent at 8 cents per share

LBT Innovations (LBT) has appointed Joanne Moss as the company’s new Chair-Elect as it looks to rejuvenate its board.

The healthcare stock announced the news on Thursday, revealing Ms Moss would first begin working for LBT as a Non-Executive Director.

The company said she’ll then move into the Independent Chair role in September this year, when outgoing Chair Kate Costello retires.

Ms Moss currently works as a Non-Executive Director of Ellume — a digital diagnostic company that works in partnership with GSK, Qiagen and the US Government.

LBT said the new leader’s experience in US commercialisation, deal strategy, scale-up and capital raising would prove very useful for the business as it continues to sell its technology in the region.

Commenting on the new role, Ms Moss said she was excited to be joining LBT.

“LBT is an example of Australian innovation at its finest and I am delighted to join the team,” Ms Moss said.

“LBT is in the early stages of global commercialisation of its ground-breaking technology and I very much look forward to sharing my knowledge and
experience to help fast track LBT’s future growth and success.”

Meanwhile, Ms Costello said she was pleased to see Ms Moss replace her and would help provide a succesful transition.

“Joanne has a deep understanding of the commercial pressures facing technology focused organisations and the challenges associated with scale-up and global commercialisation,” Ms Costello said.

“We are thrilled to have Joanne join our board and I am personally looking forward to working alongside her as she transitions to the role of Chair of the company.”

LBT Innovations ended Thursday trading up 5.26 per cent at 8 cents per share.

LBT by the numbers
More From The Market Herald
Dimerix (ASX:DXB) - Managing Director and CEO, Nina Webster

" Dimerix (ASX:DXB) expands DMX-200 study into Australia

Dimerix (DXB) has entered an agreement with the NHMRC Clinical Trials Centre at the University of Sydney to expand the CLARITY 2.

" ACCC scrambles to halt Virtus Health’s (ASX:VRT) purchase of Healius (ASX:HLS) IVF clinics

The ACCC has taken “a significant step” as it seeks an urgent injunction to stop Virtus Health’s (VRT) proposed acquisition of Adora Fertility
IDT Australia (ASX:IDT) - Chair, Alan Fisher

" IDT Australia (ASX:IDT) signs manufacturing deal with Monash University

IDT Australia (IDT) has entered a master services agreement and services order with Monash University.
Prescient Therapeutics (PTX) - CEO and MD, Steven Yatomi Clarke

" Prescient Therapeutics (ASX:PTX) to present new OmniCAR data at conference

Prescient Therapeutics (PTX) will present new results for its OmniCAR drug at the Cell & Gene Meeting on Mesa in California.